Authors

Muscular Dystrophy Association: A Hybrid Conference Featuring the Latest Advances in Neuromuscular Research, Therapy, and Clinical Care

The Muscular Dystrophy Association's annual meeting will take place in-person and virtually in Nashville, Tennessee, on March 13-16, with more than 950 in-person attendees and 130 presenters.

Therapeutics Aim at Modifying Alzheimer Disease

Disease-modifying agents will require early detection, including comprehensive evaluation of disease severity and alternative or confounding diagnoses. When the long-awaited moment arrives, when disease-modifying therapies finally are available for ADRDs…will we be ready?

A Team Approach to Asleep Deep Brain Stimulation

Henry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care has helped them become a leading treatment center for Parkinson disease and related movement disorders.

Comparable Evidence of Telehealth Benefits vs In-Person Care for Pediatrics: Gogi Kumar, MD

The division chief of child neurology at Dayton Children’s Hospital discussed findings from a study comparing patient satisfaction scores between telehealth and in-person visits in pediatric epilepsy care. [WATCH TIME: 4 minutes]

Durability and Next Steps in Advancing ARCUS Gene Editing Platform in DMD: Cassandra Gorsuch, PhD

The chief scientific officer at Precision Biosciences provided clinical insights on the durable potential of ARCUS gene editing and the company’s next steps toward in-human trials for Duchenne muscular dystrophy. [WATCH TIME: 4 minutes]

Advocacy and Empowerment: Finding Your Advocacy Community

The Palatucci Advocacy Leadership Forum, or PALF, sponsored by the American Academy of Neurology, gives neurologists and trainees tools to successfully advocate for their ideas and develop their identity as physician advocates.

Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

Lassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.

Insights on the Newly Approved Subcutaneous Infusion Therapy for Parkinson Disease

Jonathan Rubin, MD, MBA, chief medical officer at Supernus Pharmaceuticals, talked about the recent approval of the company’s subcutaneous infusion therapy SPN-830 for Parkinson disease.

Let’s Get Moving: A Multidisciplinary Approach to Gait Rehabilitation in Multiple Sclerosis

Current research pushes to advance therapeutic possibilities and understand underlying neural mechanisms for gait impairments in individuals with the disease.

Purple Day Every Day For Epilepsy Awareness

Alzheimer Disease: Promising Advances Give Patients and Families Hope

William Hu, MD, PhD, FAAN, a neurologist at RWJBarnabas Health’s Robert Wood Johnson University Hospital in New Brunswick, NJ, shared new advances to detect and treat Alzheimer disease.

Top 8 Neurology Apps

With promising names like "5-Minute Neurology Consult" and "Neurosurgery Survival Guide" the mobile applications in this top-pick list provide immediate and encyclopedic access to the nuts, bolts, and nuances of neurologic practice.

Driving with Cognitive Impairment

Investigators questioned whether cognitive tests could predict driving ability in people with Alzheimer disease and mild cognitive impairment.

What Caused Altered Consciousness in This Middle-Aged Woman?

Take a look at these 3 images and see if you can pinpoint the cause of altered consciousness in this woman.

Neuro-Ophthalmologic Disorders: Issues in Diagnosis and Treatment

Neurologists may be the first or only clinicians to recognize the 5 potentially dangerous neuro-ophthalmologic conditions described in this article.

Epilepsy: Psychological & Behavioral Interventions

There is a pressing need for effective interventions aimed at enhancing psychological well-being and self-management for epilepsy patients.

Sleep Characteristics and Cognition in the Elderly

The HypnoLaus study compared sleep characteristics of individuals older than 65 years of age with and without cognitive impairment.

The Sports Neurologist: A Welcome Addition to the Sideline

Perhaps the Nose Knows: UPSIT and Alzheimer Disease

Does smell identification have any predictive value for later Alzheimer disease?

Stroke Risk Tied to Subjective Memory Complaints

Inquiring about memory in older persons during routine clinical examination may identify persons who might be at higher risk for stroke.

Diazepam as Effective as Lorazepam for Pediatric Status Epilepticus

A Smartphone Approach to Alzheimer Disease Diagnosis and Progression

Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.

Post-coital Headache

A sudden severe headache with emesis brings a 35-year-old man to the ED. Research on his smart phone has satisfied him that this is a post-coital event and therefore, harmless. He refuses a lumbar puncture.

Tools to Offer TLC for Hatred of Sound

There is no approved screening tool for misophonia, but a case review can lead to a diagnosis. Several treatment options may aid in symptom management.

A Smartphone Approach to Alzheimer Disease Diagnosis and Progression

Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.

A Smartphone Approach to Alzheimer Disease Diagnosis and Progression

Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.

Pinning Down the Site of Infarct in a Woman With Altered Consciousness

Concurrent CGRP Inhibitor and OnabotulinumtoxinA Therapy Boosts Relief in Severe Chronic Migraine

For years, study participants had been suffering with migraine symptoms and had failed at least three to five therapies before enrolling in the trial.

Tingling, Numbness in Lower Limbs: A Case Study

What do these images suggest is the cause of bilateral lower limb symptoms of 4 months’ duration?